Lars Erik Bryld
Clinical Associate Professor
1 - 2 out of 2Page size: 10
- 2017
- Published
Characteristics of patients receiving ustekinumab compared with secukinumab for treatment of moderate-to-severe plaque psoriasis: nationwide results from the DERMBIO registry
Egeberg, A., Iversen, L., Gniadecki, R., Hvid, L., Dam, T. N., Bryld, Lars Erik & Skov, Lone, 2017, In: Journal of the European Academy of Dermatology and Venereology. 31, 7, p. 1183-1187Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Treatment history of patients receiving biologic therapy for psoriasis
Loft, N., Skov, Lone, Bryld, Lars Erik, Gislason, Gunnar Hilmar & Egeberg, A., 2017, In: Journal of the European Academy of Dermatology and Venereology. 31, 8, p. e362-e363Research output: Contribution to journal › Comment/debate › Research
ID: 32369880
Most downloads
-
77
downloads
Patient-reported Outcomes During Treatment in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Study
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
18
downloads
Response to biologics during the first six months of therapy in biologic-naïve patients with psoriasis predicts risk of disease flares: A danish nationwide study
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
11
downloads
Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study
Research output: Contribution to journal › Comment/debate › Research › peer-review
Published